Purpose To assess the prevalence and nature of incidental findings (IF) seen in low-dose computed tomographies (LDCT) from a lung cancer screening study for at-risk individuals. Materials and Methods Radiology reports from LDCTs of 4073 participants of a lung cancer screening study were retrospectively reviewed for findings other than lung nodules, that is, IFs, which were regarded as actionable. The frequency, nature, and expected cost of these IFs, and their anticipated follow-up were estimated. Results There were 880 IFs described in 782 study participants (19%); the median age of the participants was 62 years (range, 46–80 years). More IFs were found in men (55%) than in women. The majority of these findings were noncardiovascular (76%), for which imaging was suggested for 74%. There were 7 severe IFs (0.8%) that merited immediate attention. Seven known cancers were diagnosed from follow-ups of the IFs. The majority of IFs ( n = 486 [55%]) would require imaging follow-up if clinically indicated, with an estimated total a cost of CAN$45,500 to CAN$51,000 to provide initial diagnostic workup. Conclusion IFs on lung cancer screening studies are not uncommon and frequently require imaging or other follow-up for definitive diagnoses and to assess their clinical relevance. The implication of IFs has to be considered when determining a cost-effective and ethical protocol for the utilisation of LDCT in a high-risk population.
Care Burden Derived from the Introduction of an Early Lung Cancer Screening Program in High-Risk HIV-Infected Patients
